Neuzumab 440mg Injection

Product Description

Neuzumab 440mg Injection contains Trastuzumab, an active ingredient used in the treatment of HER2-positive breast cancer. In patients with HER2-positive cancer, the cancer cells have an abundance of HER2 proteins, which promote rapid tumor growth. This medication is also effective in treating metastatic gastric cancer that exhibits elevated levels of HER2 proteins.

HER2-positive breast cancer is particularly aggressive. The targeted therapy provided by Neuzumab 440mg works by selectively attacking the HER2 proteins responsible for cancer cell growth, development, and spread. Patients should use reliable contraception during treatment and for at least seven months after the final dose.

Neuzumab 440mg Injection is not recommended for patients under 18 years old or those with severe respiratory issues requiring oxygen therapy. It is important to inform your doctor if you have any heart conditions, experience shortness of breath, or have previously undergone cancer treatments. Additionally, make sure to disclose all medications, including supplements and herbal remedies, before beginning Neuzumab treatment.